Announcements Trials

Browse Landscape

Phase

Phase 2 22 Phase 1 12 Phase NA 7 Phase EARLY_PHASE1 3 Phase 3 3 Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroendocrine Tumors 43 Carcinoma, Neuroendocrine 22 Small Cell Lung Carcinoma 13 Carcinoma, Non-Small-Cell Lung 12 Neoplasms 11 Sarcoma 10 Lung Neoplasms 9 Thyroid Carcinoma, Anaplastic 7 Thyroid Cancer, Papillary 7 Stomach Neoplasms 7 Pheochromocytoma 7 Paraganglioma 7 Head and Neck Neoplasms 7 Gastro-enteropancreatic neuroendocrine tumor 7 Carcinoid Tumor 7 Thyroid Neoplasms 6 Neoplasm Metastasis 6 Colorectal Neoplasms 6 Ovarian Neoplasms 5 Breast Neoplasms 5 Uterine Cervical Neoplasms 4 Thyroid Diseases 4 Thoracic Neoplasms 4 Respiratory Tract Neoplasms 4 Respiratory Tract Diseases 4 Prostatic Neoplasms 4 Neuroblastoma 4 Neoplasms by Site 4 Multiple Endocrine Neoplasia Type 1 4 Lung Diseases 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Insulinoma × Endocrine × Clear all

NCT03189953 2021-06-16

GLP-1-AHH

Radboud University Medical Center

Phase 1/2 Completed

Insulinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡